Embolx

Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation family of Sniper Balloon Occlusion Microcatheters for pressure-directed arterial embolization therapy. Now commercially available in the United States, the next-generation family of Sniper devices offers physicians enhanced performance features to improve access and allow easy navigation through small complex vascular structures.